Skip to main content
logo
Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
6.87
-0.10 (-1.43%)
At close: Mar 4, 2026, 4:00 PM EST
6.87
0.00 (0.00%)
After-hours: Mar 4, 2026, 5:38 PM EST

Telix Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2,2662,5375,155---
Market Cap Growth
-60.46%-50.78%----
Enterprise Value
2,6102,8635,075000
Last Close Price
6.877.4915.40---
PE Ratio
--354.98157.79---
Forward PE
92.15-----
PS Ratio
2.823.169.98---
PB Ratio
5.456.1114.61---
P/TBV Ratio
5.596.0915.06---
P/FCF Ratio
--59.03280.56---
P/OCF Ratio
--146.73187.51---
EV/Sales Ratio
3.253.569.82---
EV/EBITDA Ratio
80.4155.9383.94---
EV/EBIT Ratio
135.3496.1491.98---
EV/FCF Ratio
--66.60276.22---
Debt / Equity Ratio
1.121.121.02-0.131.18
Debt / EBITDA Ratio
9.139.135.96---0.03
Debt / FCF Ratio
-10.87-10.8719.60---0.04
Net Debt / Equity Ratio
0.780.78-0.23--1.32-9.03
Net Debt / EBITDA Ratio
6.356.35-1.32--0.26
Net Debt / FCF Ratio
-7.57-7.57-4.34--0.32
Asset Turnover
0.760.761.103.8300.05
Inventory Turnover
12.4312.4315.2742.8003.09
Quick Ratio
1.171.172.57-1.821.10
Current Ratio
1.431.432.78-2.021.25
Return on Equity (ROE)
-1.85%-1.85%19.09%15.46%0.00%-187.51%
Return on Assets (ROA)
3.83%3.83%10.43%20.55%0.00%-54.30%
Return on Invested Capital (ROIC)
6.27%6.27%23.71%58.64%0.00%-106.05%
Return on Capital Employed (ROCE)
3.57%3.57%15.01%19.05%0.00%-69.07%
Earnings Yield
-0.31%-0.28%0.63%---
FCF Yield
-1.90%-1.69%0.36%---
Buyback Yield / Dilution
-0.07%-0.07%-0.01%---
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q